US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kardigan

21.02

+0.76003.75%

Post-market: 21.020.00000.00%19:30 EDT

Volume:159.58K

Turnover:3.35M

Market Cap:1.97B

PE:-6.80

High:21.76

Open:20.47

Low:20.46

Close:20.26

52wk High:27.00

52wk Low:16.25

Shares:93.50M

Float Shares:23.33M

Volume Ratio:0.78

T/O Rate:0.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0900

EPS(LYR):-14.8367

ROE:--

ROA:--

PB:3.19

PE(LYR):-1.42

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Kardigan

Exchange:

NASDAQ

Establishment Date:

2023

Employees:

- -

Office Location:

506 Carnegie Center Drive,Suite 201,Princeton,New Jersey,United States

Website:

http://www.kardigan.bio

Zip Code:

08540

Phone:

Fax:

- -

Introduction:

Kardigan, Inc. was incorporated in Delaware in August 2023. The company is a clinical-stage precision therapeutics company focused on developing drugs that target the root causes of specific cardiovascular diseases for which no approved therapies currently exist. It has three late-stage clinical programs—Danicamtiv, Ataciguat, and Tonlamarsen—and leverages its proprietary Prolaio platform along with deep cardiovascular expertise to efficiently advance targeted therapies addressing fundamental disease mechanisms rather than downstream symptoms.

Directors

Name

Position

Tassos Gianakakos

Chair and Chief Executive Officer and Director

David Meeker

Director

Douglas Giordano

Director

Kim Popovits

Director

Paul Berns

Director

Tim Walbert

Director

Shareholders

Name

Position

Tassos Gianakakos

Chair and Chief Executive Officer and Director

Brianne Puglisi

Chief Financial Officer

Andy Pasternak

Chief Strategy Officer

Jay Edelberg

Chief Medical Officer

John B. Moriarty, Jr.

Chief Legal Officer and Corporate Secretary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/KARD/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","market":"US","secType":"STK","nameCN":"Kardigan","latestPrice":21.02,"timestamp":1787342400000,"preClose":20.26,"halted":0,"volume":159580,"hourTrading":{"tag":"盘后","latestPrice":21.02,"preClose":21.02,"latestTime":"19:30 EDT","volume":2518,"amount":52928.68,"timestamp":1787355007374,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03751233958538983,"floatShares":23333300,"shares":93503699,"eps":-3.09,"marketStatus":"Market Closed","change":0.76,"latestTime":"08-21 16:00:00 EDT","open":20.47,"high":21.755,"low":20.46,"amount":3354890.2350000003,"amplitude":0.063919,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.09,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1781755200000,"exchange":"NASDAQ","adjPreClose":20.26,"preHourTrading":{"tag":"盘前","latestPrice":21.99,"preClose":20.26,"latestTime":"09:28 EDT","volume":129,"amount":2729.109939,"timestamp":1787318890882,"change":1.73,"changeRate":0.08539,"amplitude":0.075025},"postHourTrading":{"tag":"盘后","latestPrice":21.02,"preClose":21.02,"latestTime":"19:30 EDT","volume":2518,"amount":52928.68,"timestamp":1787355007374,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7764392196580752},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","floatShares":23333300,"roa":"--","roe":"--","lyrEps":-14.836702,"volumeRatio":0.7764392196580752,"shares":93503699,"dividePrice":0,"high":21.755,"amplitude":0.063919,"preClose":20.26,"low":20.46,"week52Low":16.25,"pbRate":"3.19","week52High":27,"institutionHeld":0,"latestPrice":21.02,"eps":-3.09,"divideRate":0,"volume":159580,"delay":0,"ttmEps":-3.09,"open":20.47,"prevYearClose":16,"prevWeekClose":20.2,"prevMonthClose":20.82,"prevQuarterClose":23.85,"fiveDayClose":20.2,"twentyDayClose":20.74,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KARD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KARD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KARD","date":"2026-08-21","current":-6.802589,"percent":0.97619,"low":-10.060668,"twenty":-9.156374,"median":-8.417555,"eighty":-7.800708,"high":-6.540441,"avg":-8.329277,"sd":0.859007,"marketCap":1894384941},"quantilePoints":[{"date":"2026-06-26","current":-8.771038,"twenty":-8.785799,"median":-8.638967,"eighty":-8.555064,"marketCap":2017277352},{"date":"2026-07-02","current":-9.365355,"twenty":-9.304758,"median":-8.844842,"eighty":-8.606338,"marketCap":2153966207},{"date":"2026-07-10","current":-9.497426,"twenty":-9.402646,"median":-9.202209,"eighty":-8.63586,"marketCap":2184341508},{"date":"2026-07-17","current":-8.165067,"twenty":-9.402646,"median":-9.140059,"eighty":-8.601677,"marketCap":1877908323},{"date":"2026-07-24","current":-8.417555,"twenty":-9.304758,"median":-8.862322,"eighty":-8.544187,"marketCap":1935978752},{"date":"2026-07-31","current":-7.951424,"twenty":-9.261253,"median":-8.708887,"eighty":-8.273054,"marketCap":1828771806},{"date":"2026-08-07","current":-7.908695,"twenty":-9.248823,"median":-8.631199,"eighty":-8.113793,"marketCap":1818944503},{"date":"2026-08-14","current":-7.061734,"twenty":-9.209201,"median":-8.551568,"eighty":-7.960747,"marketCap":2039315675},{"date":"2026-08-21","current":-6.559868,"twenty":-9.156374,"median":-8.417555,"eighty":-7.800708,"marketCap":1894384941}],"updateTime":1787525419719},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1916374431,"yearFounded":2023,"address":"506 Carnegie Center Drive,Suite 201,Princeton,New Jersey,United States","zipCode":"08540","officePhone":"(415) 573-3220","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.kardigan.bio","stockEarnings":[{"period":"1week","weight":0.0406},{"period":"1month","weight":-0.0805},{"period":"3month","weight":0.3137},{"period":"ytd","weight":0.3137}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kardigan, Inc. was incorporated in Delaware in August 2023. The company is a clinical-stage precision therapeutics company focused on developing drugs that target the root causes of specific cardiovascular diseases for which no approved therapies currently exist. It has three late-stage clinical programs—Danicamtiv, Ataciguat, and Tonlamarsen—and leverages its proprietary Prolaio platform along with deep cardiovascular expertise to efficiently advance targeted therapies addressing fundamental disease mechanisms rather than downstream symptoms.","exchange":"NASDAQ","name":"Kardigan","nameEN":"Kardigan"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KARD\",market:\"US\",,,undefined,":{"directors":[{"name":"Tassos Gianakakos","position":"Chair and Chief Executive Officer and Director"},{"name":"David Meeker","position":"Director"},{"name":"Douglas Giordano","position":"Director"},{"name":"Kim Popovits","position":"Director"},{"name":"Paul Berns","position":"Director"},{"name":"Tim Walbert","position":"Director"}],"executives":[{"name":"Tassos Gianakakos","position":"Chair and Chief Executive Officer and Director"},{"name":"Brianne Puglisi","position":"Chief Financial Officer"},{"name":"Andy Pasternak","position":"Chief Strategy Officer"},{"name":"Jay Edelberg","position":"Chief Medical Officer"},{"name":"John B. Moriarty, Jr.","position":"Chief Legal Officer and Corporate Secretary"}]}}}